{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = [(8''R'',9''S'',10''R'',13''S'',14''S'',17''S'')-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1''H''-cyclopenta[''a'']phenanthren-17-yl] decanoate
| image = Nandrolone decanoate.svg
| width = 250px
| image2 = Nandrolone decanoate molecule ball.png
| width2 = 250px

<!--Clinical data-->
| tradename = Deca-Durabolin, others
| pregnancy_AU = D
| pregnancy_US = X
| pregnancy_category = 
| legal_AU = S4
| legal_CA = Schedule IV
| legal_UK = Class C
| legal_US = Schedule III
| legal_status = 
| routes_of_administration = [[Intramuscular_injection|Intramuscular injection]]
| class = [[Androgen|Androgen]]; [[Anabolic_steroid|Anabolic steroid]]; [[Androgen_ester|Androgen ester]]; [[Progestogen|Progestogen]]

<!--Pharmacokinetic data-->
| bioavailability = [[Intramuscular_injection|Intramuscular]]: 53–73%<ref name="pmid15713722">{{cite journal | vauthors = Bagchus WM, Smeets JM, Verheul HA, De Jager-Van Der Veen SM, Port A, Geurts TB | title = Pharmacokinetic evaluation of three different intramuscular doses of nandrolone decanoate: analysis of serum and urine samples in healthy men | journal = J. Clin. Endocrinol. Metab. | volume = 90 | issue = 5 | pages = 2624–30 | year = 2005 | pmid = 15713722 | doi = 10.1210/jc.2004-1526 | url = }}</ref>
| protein_bound = 
| metabolism = [[Blood|Blood]] ([[hydrolysis|hydrolysis]]), [[liver|liver]] ([[redox|reduction]])<ref name="Label-NZ" /><ref name="Thomas2012" />
| metabolites = • [[Nandrolone|Nandrolone]]<ref name="Label-NZ" /><ref name="Llewellyn2011" /><br />• [[5α-Dihydronandrolone|5α-Dihydronandrolone]]<ref name="Label-NZ" /><ref name="Llewellyn2011" /><br />• [[19-Norandrosterone|19-Norandrosterone]]<ref name="Label-NZ" /><br />• [[19-Noretiocholanolone|19-Noretiocholanolone]]<ref name="Label-NZ" /><br />• [[Conjugation_(biochemistry)|Conjugate]]s<ref name="Thomas2012" />
| elimination_half-life = • Intramuscular: 6–12 days<ref name="Label-NZ">http://www.medsafe.govt.nz/profs/Datasheet/d/Decadurabolininj.pdf</ref><ref name="pmid9103484">{{cite journal | vauthors = Minto CF, Howe C, Wishart S, Conway AJ, Handelsman DJ | title = Pharmacokinetics and pharmacodynamics of nandrolone esters in oil vehicle: effects of ester, injection site and injection volume | journal = J. Pharmacol. Exp. Ther. | volume = 281 | issue = 1 | pages = 93–102 | year = 1997 | pmid = 9103484 | doi = | url = }}</ref><br />• Nandrolone: <4.3 hours<ref name="Label-NZ" />
| duration_of_action = • Intramuscular: 2–3 weeks<ref name="Llewellyn2011" /><ref name="Label-AU" />
| excretion = [[Urine|Urine]]<ref name="Label-NZ" />

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 360-70-3
| CAS_supplemental = 
| ATC_prefix = 
| ATC_suffix = 
| PubChem = 9677
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 9296
| UNII = H45187T098
| synonyms = • Nandrolone decylate<br />• 19-Nortestosterone 17β-decanoate

<!--Chemical data-->
| C=28 | H=44 | O=3
| SMILES = CCCCCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C
| StdInChI_Ref = 
| StdInChI = 1S/C28H44O3/c1-3-4-5-6-7-8-9-10-27(30)31-26-16-15-25-24-13-11-20-19-21(29)12-14-22(20)23(24)17-18-28(25,26)2/h19,22-26H,3-18H2,1-2H3/t22-,23+,24+,25-,26-,28-/m0/s1
| StdInChIKey_Ref = 
| StdInChIKey = JKWKMORAXJQQSR-MOPIKTETSA-N
}}
<!-- Definition and medical uses -->
{{medical}}
'''癸酸诺龙'''（{{lang-en|Nandrolone decanoate}}，[[商品名|商品名]]为Deca-Durabolin）是一种[[雄激素|雄激素]][[同化類固醇|同化類固醇]]（AAS）[[药物|药物]]，主要用于治疗[[贫血|贫血]]与[[惡病體質|惡病體質]]，以及患[[骨質疏鬆症|骨質疏鬆症]]的[[更年期|更年期]]女性<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA660|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=660–}}</ref><ref name="IndexNominum2000">{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA716|date=January 2000|publisher=Taylor & Francis|isbn=978-3-88763-075-1|pages=716–717}}</ref><ref name="MortonHall2012">{{cite book|author1=I.K. Morton|author2=Judith M. Hall|title=Concise Dictionary of Pharmacological Agents: Properties and Synonyms|url=https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA189|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-94-011-4439-1}}</ref><ref name="Drugs.com">https://www.drugs.com/international/nandrolone.html</ref><ref name="Llewellyn2011">{{cite book|author=William Llewellyn|title=Anabolics|url=https://books.google.com/books?id=afKLA-6wW0oC&pg=PT402|year=2011|publisher=Molecular Nutrition Llc|isbn=978-0-9828280-1-4|pages=402–412,193–194}}</ref>。通过每1-4周一次的[[肌肉注射|肌肉注射]]进行给药<ref name="Llewellyn2011" />。
[[File:Nandrolone.svg|thumb]]（Nandrolone，'''诺龙'''），癸酸诺龙的最终[[活性代謝產物|活性形式]]]]
==参考文献==
<references />
{{雄激素}}

[[Category:前药|Category:前药]]
[[Category:醇|Category:醇]]
[[Category:烯烃|Category:烯烃]]
[[Category:雌激素类|Category:雌激素类]]
[[Category:酮|Category:酮]]
[[Category:孕激素类|Category:孕激素类]]
[[Category:癸酸酯|Category:癸酸酯]]